George Kollias
@KolliasLab
Followers
490
Following
184
Media
15
Statuses
271
RT @NatImmunol: Great group photo of all the attendees at the Aegean Conference on Mesenchymal Cells in Health and Disease.
0
2
0
RT @SMuellerLab: Approaching fast. A beautiful setting for a fantastic meeting on stromal cells. Register now!.
0
3
0
Highly recommended! .Little time left to secure one of our last seats!.@AegeanConf @BSRC_Fleming #fibroblast #stroma #mesenchymalcells #inflammation #immunity #cancer #fibrosis
0
1
14
A wonderful collaboration with the medicinal chemistry lab of Alexios Matralis and valued colleagues! First small molecule leads targeting #fibroblast activation driving chronic #inflammatorydisease and #fibrosis.
Discovery of the First-in-Class Inhibitors of Hypoxia Up-Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast Activation (George Kollias and co-workers) @KolliasLab
1
6
20
Shine bright! 👏.
Thrilled that my article made it to the Top 10 most-downloaded! Grateful for the support @NatureRevCancer @BSRC_Fleming #MustRead.
0
0
11
RT @guilderstern: Περισσότερο από "2η Έκδοση" είναι ένα καινούργιο βιβλίο, με πέντε νέα κεφάλαια, επικαιροποιημενο υλικό, ερωτήσεις, ασκήσε….
0
9
0
Yes! It's public! Our lab's new work providing the first evidence of spatial spreading of intestinal inflammation via distinct fibroblast subsets. Amazing work . all because of amazing Lida et al! @BSRC_Fleming @CrohnsColitisFn @ERC_Research
biorxiv.org
Crohn’s disease represents a persistent inflammatory disorder primarily affecting the terminal ileum. Through the application of single-cell RNA sequencing, we unveil the intricate cellular complex...
0
6
56
RT @DimPapad02: An antipsychotic drug reduces arthritis in a fibroblast dependent model! Take a look on our work from @KolliasLab at @BSRC_….
0
5
0
RT @WillisakaRick: This one is a must read for all physiology students and a great set of figures for instructors.
0
6
0
Amazing and 'touching' progress Maria! Kudos!.
Two touches are better than one🤓 Our novel concepts on immune stimulating #mesenchymal cells across tissues @NatureRevCancer Plus a reworked model of the “Cancer Immunity Cycle” based on antigen-presenting #fibroblasts and the “Second Touch Hypothesis”👉
0
0
1
So very proud @BSRC_Fleming on our fourth currently running @ERC_Research grant! Deservedly the new CoG to @tsoumakidou lab! Congrats Maria . amazing performance and enjoy!.
📢 The results of the 2022 ERC Consolidator Grant competition are out: €657 million for 321 researchers. Who has been offered funding?.What topics they will investigate?.Where will they do their research?. Discover the details ➡️ 🇪🇺#EUfunded #ERCCoG
0
3
33
📢#Recruiting #Bioscientist #postdocs to join our team @KolliasLab @BSRC_Fleming | #inflammation #fibrosis #biomedicalresearch @ERC_Research | #APPLY by January 15 👉
0
8
17
📢#Recruiting motivated #Bioinformatician at the #postdoctoral level to join our labs #SingleCell Analysis Unit @KolliasLab | #singlecell #scRNAseq #MultiOME #spatialtranscriptomics #biomedicalresearch @BSRC_Fleming @ERC_Research | #APPLY by January 31 👉
0
5
13
RT @g_pavlopoulos: Single cell RNAseq and ATAC sec made easy. Please find online our complete solution, SCALA.
biorxiv.org
Analysis and interpretation of high-throughput transcriptional and chromatin accessibility data at single cell resolution are still open challenges in the biomedical field. In this article, we...
0
4
0
RT @FrontImmunol: New Research: Autoimmunity: Are we asking the right question?: For decades, the main question immunologists have asked ab….
0
3
0
RT @physiolrev: Dr. Mihai G. Netea, @dominjor, and colleagues from @GeneticNijmegen provide an extensive #review of #InnateImmunity, includ….
0
2
0
RT @BSRC_Fleming: The #Genomics and #PrecisionMedicine Facility @BSRC_Fleming is seeking a senior #Bioscientist to drive its research and….
0
8
0
Highly recommended! Spread the word or go for it!.
@tsoumakidou LAB @BSRC_Fleming is seeking motivated #ResearchAssistant #postdoc to study #DendriticCell #fibroblasts as #Cancer #Antigen presenting cells using #human #MouseModel of #LungCancer for novel #immunotherapies. #BiomedicalResearch .#ApplyNow:
0
3
7